To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

Post Archives

June 7, 2024
FDA Approval for Pediatric Low Grade Glioma Drug

Tovorafenib has received FDA approval for treating low-grade glioma in children.

Read More
May 30, 2024
GBM: Significant Survival Data Announced

The Ivy Brain Tumor Center has announced that treatment with niraparib achieved significant improvement in survival data for newly diagnosed glioblastoma patients.

Read More
May 28, 2024
What is ZAP-X® to Treat Brain Cancer?

ZAP-X® looks to set new standards in surgical robotics, radiosurgical safety and efficacy, as well as patient comfort in the treatment of brain cancer.

Read More
May 23, 2024

The End Brain Cancer Initiative (EBCI) will attend the 2024 ASCO Annual Meeting and would like to meet with pharm to discuss partnership.

Read More
May 21, 2024
Announcing 2024’s National HOPE Award Recipient

We are proud to present the 2024 National HOPE Award to Patrick "Paddy" O'Donnell!

Read More
May 16, 2024
WA State Brain Tumor Awareness Day

May 18th, 2024 proclaimed as Brain Tumor Awareness Day in Washington State.

Read More
May 13, 2024
3 Brain Cancer Patients Who Are Inspiring HOPE

Every May EBCI has presented the HOPE award to a brain cancer patient who inspires us with their courage and hope in the face of this devastating disease.

Read More
May 9, 2024
Register for Access to GBM 3D-Predict Testing

At KAYTO 2024, Eric will provide education on Kiyatec's 3D-Predict™ test, which helps predict which treatment is likely to be the most effective for your specific tumor tissue.

Read More
May 6, 2024
Learn More About A New Radiation Treatment for Brain Tumors

At KAYTO 2024, Dr. Hanft will provide education on GammaTile's Surgically Targeted Radiation Therapy (STaRT).

Read More
May 3, 2024
Today, YOU Can Provide Life-Saving Resources and Services

Give Big to make a difference in the lives of GBM patients. No one should have to face a GBM diagnosis alone.

Read More
April 29, 2024
EBCI Welcomes New Board Member Pat Jones

Welcome Pat Jones to the End Brain Cancer Initiative as the newest member of our Advisory & Scientific Board.

Read More
April 29, 2024
Know All Your Treatment Options: FREE Registration Open Now

Register now for the Know All Your Treatment Options webinar, produced and moderated by the End Brain Cancer Initiative (EBCI).

Read More


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram